The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

“I would like to come to a point where we cure even more children that are diagnosed with leukaemia”

Wallenberg Molecular Medicine Clinical Researcher - Kees-Jan Pronk

The focus of paediatric oncologist Kees-Jan Pronk’s research is to find out what happens with the blood system in children that develop leukaemia. The other focus of his research is to reduce side effects of leukaemia treatments. “We are trying to find ways to reduce the side effects, but still keeping the treatment as effective as it is.”

Kees-Jan Pronk is a senior consultant in paediatric oncology at Skåne University Hospital and a researcher at Wallenberg Centre for Molecular Medicine (WCMM). In 2022, every week a researcher working at WCMM at Lund University and Skåne University Hospital is presented. In the video, Kees-Jan Pronk shares more about his research.  

About Wallenberg Centre for Molecular Medicine 

  • Wallenberg Centre for Molecular Medicine (WCMM) is a research centre focused on Regenerative and Translational Medicine.
  • Through integrated research environments and excellent infrastructure, conditions are created for world-leading molecular and translational research.
  • The research at the Wallenberg Centre for Molecular Medicine was made possible by generous funding from the Knut and Alice Wallenberg Foundation, the Region Skåne and the Faculty of Medicine at Lund University. The Knut and Alice Wallenberg Foundation is making a nationwide effort to ensure that Sweden regains a world-leading position in medical research.